5 Steps to Vet a Medical Marketing Consultant

What Verifiable Behavioral Health Case Studies Should Contain

Case studies from dermatology, dental services, or general hospital SEO do not adequately demonstrate expertise in addiction treatment. Behavioral health marketing involves unique substantiation standards, referral regulations, and confidentiality obligations. Therefore, verifiable sector-specific evidence is crucial.

A robust case study should include five key elements:

1. A named client the consultant is authorized to reference, or a redacted study with underlying documentation available under NDA.
2. Specific admissions-relevant outcomes measured, such as qualified inbound calls, VOB completions, admissions, or cost per admission, rather than metrics like sessions or keyword rankings.
3. The time frame and baseline for the reported results, ensuring the lift isn’t a seasonal anomaly.
4. Details on channels and spend to differentiate paid media impact from organic growth.
5. The compliance controls implemented, including how PHI was excluded from analytics, how claims were reviewed, and whether a business associate agreement was in place.

Case studies lacking these details describe activity, not measurable results. Request the raw reporting export, not just a summary slide.

Disqualifiers Hidden in a Consultant’s Own Ad Behavior

A consultant’s live paid-search activity often reveals more than their presentation. Before a second meeting, a CMO should analyze the consultant’s current and past client domains using an ad-transparency tool. This reveals their typical tactics.

The FTC’s complaint against Evoke Wellness detailed how the operator ran over 68,510 misleading Google search ads, impersonating other SUD providers and routing callers to an undisclosed call center ¹. This demonstrates the scale of conduct now under enforcement scrutiny. A consultant whose portfolio includes competitor-brand keyword bidding, ad headlines using other facilities’ names, generic “national helpline” landing pages without clear provider identification, or click-to-call flows leading to unnamed centralized intake teams is exhibiting patterns that the FTC has already addressed through settlements and injunctions ².

Specific disqualifiers to note include:

• Bidding on competitor facility names in the consultant’s own case history
• Landing pages that do not clearly identify the treating provider
• Call flows that fail to disclose the answering entity immediately
• “Treatment finder” or “admissions hotline” microsites without clear operator identity
• Testimonial-heavy pages lacking substantiation

Any of these should be considered a disqualifier, not a point for discussion. A consultant defending such practices as industry standard indicates a high-risk profile for the treatment center.

The AWAREmed Standard for Outcome and Comparative Claims

Every service page, ad headline, and admissions script created by a consultant represents a claim the treatment center will be responsible for. The AWAREmed case illustrates the consequences when claims lack evidence. The FTC alleged the clinic advertised its addiction treatment as rapid, painless, effective, and safe, and superior to 30-day programs, without competent and reliable scientific evidence ³. This highlights that comparative and outcome claims in behavioral health require substantiation before publication, not after an inquiry.

A consultant should provide a written claim-substantiation protocol aligned with the FTC’s Health Products Compliance Guidance. This protocol should identify express and implied messages, match them to the appropriate level of evidence, and log the supporting source before content goes live ⁴. Request to see an actual log from a recent engagement, detailing the claim, its implied message, the evidence, the reviewer, and the approval date.

Language requiring substantiation during vetting includes success rates, completion rates, sobriety percentages, “evidence-based” without a cited modality, “industry-leading,” “nation’s top,” and any comparison to length of stay, level of care, or competitors. A consultant unable to produce such a log, or who views substantiation as a post-publication legal issue, mirrors the approach that led to the AWAREmed complaint.

Alumni Stories, Endorsements, and the 2024 Fake-Reviews Rule

Alumni testimonials carry significant regulatory weight, often underestimated by treatment center CMOs. The FTC’s final rule on fake reviews and testimonials, effective October 21, 2024, prohibits creating, buying, selling, procuring from insiders, or knowingly disseminating fake or false consumer reviews, including AI-generated content presented as authentic patient experiences ⁵. A consultant unable to document how alumni stories are sourced, consented, verified, edited, and removed is proposing practices now targeted by this rule.

Endorsement guides further clarify these requirements. Endorsements must reflect genuine opinions and actual experiences, material connections must be disclosed, and even truthful individual stories can imply broader typical results requiring separate substantiation ⁶. A consultant meeting this standard will provide a testimonial workflow that includes:

• Signed consent for specific assets and channels
• Verification of program completion
• Clear differentiation and disclosure for paid or incentivized endorsements
• A removal process upon request
• A claim-review step for any implied outcomes

Two specific disqualifiers for vetting are review-generation programs offering incentives without disclosure, or filtering patients based on predicted sentiment. Also, case studies or landing pages using stock imagery presented as alumni, composite quotes attributed to real initials and cities, or AI-generated portraits for testimonials are problematic. Both fall under conduct the FTC now directly enforces against ^{5, 6}.

Which Marketing Tools Require a BAA

The marketing stack proposed by a consultant functions as a data map. Any tool interacting with form submissions, phone numbers, appointment requests, or admissions page sessions can process information that becomes PHI when combined with the treatment center’s context. HHS guidance on online tracking states that regulated entities cannot use pixels, analytics scripts, session-replay tools, or call-tracking platforms in ways that lead to impermissible PHI disclosures. If a tracking vendor meets the business associate definition, a BAA and permitted disclosure are required ⁷. The vendor’s contractual label is less important than its function ⁹.

The required vetting artifact is a written vendor-stack inventory. This should cover, at minimum:

• Call-tracking and recording platforms
• Web analytics
• Advertising pixels and conversion APIs
• Chat and form providers
• CRM and marketing automation
• Hosting and CDN
• Session replay
• Heatmapping
• Retargeting audiences
• Any subprocessors

For each, the consultant must identify what data flows to the vendor, whether it can identify a prospective or actual patient, and if a BAA is in place with defined permitted uses, safeguards, subcontractor obligations, and breach reporting timelines ^{8, 9}.

Part 2 Data Handling Across Intake, Call Recording, and Retargeting

42 CFR Part 2 establishes a higher standard than HIPAA for records identifying an individual as having or having had a substance use disorder, especially when held by a federally assisted program. This regulation restricts the use and disclosure of such records unless specific circumstances apply, and mandates patient notification at admission about federal protection of SUD record confidentiality ¹⁰. This directly impacts marketing operations more than many consultants realize.

Three data flows require detailed review:

1. Intake forms and chat transcripts: once a prospect discloses substance use, a desired level of care, or a prior admission, the resulting record may fall under Part 2 if it reaches a covered program. Consultants must demonstrate how form fields are minimized, where transcripts are stored, and which vendors can access them.
2. Call recordings and transcripts from tracking platforms and AI note-takers: the consultant should document retention periods, redaction procedures, access controls, and whether recordings are used to train vendor models.
3. Retargeting audiences and lookalike seeds built from admissions-page visitors, form starters, or callers: uploading these identifiers to an ad platform can constitute a disclosure not permitted by HIPAA or Part 2 without specific authorization ^{7, 10}.

Demand a written data-flow diagram for these three paths, noting the legal basis for each transfer. If the consultant cannot provide one, they are not suitable for the account.

Compensation Structures That Trigger DOJ and State Anti-Brokering Exposure

Compensation arrangements are a critical area where marketing engagements can lead to criminal exposure. The DOJ’s Sober Homes initiative, under the Rapid Response Strike Force, targets individuals who offer illegal financial incentives to enroll patients, bill for unnecessary services, or steer patients away from appropriate care ¹¹. A per-admission fee paid to a marketing consultant falls into the same category of arrangement examined by the Strike Force.

The vetting rule is clear: fees should compensate for defined work product and media, not per-patient outcomes. Retainers, hourly rates, project fees, and media management percentages tied to ad spend generally do not raise brokering concerns. However, arrangements like the following do raise such questions:

• Pay-per-admit
• Pay-per-VOB-completed
• Pay-per-qualified-call (where “qualified” is based on insurance benefits rather than clinical fit)
• Revenue-share on collected reimbursement
• Bonuses tied to census thresholds

This also applies to any subcontractors, such as call centers or SEO vendors, whose compensation is linked to the treatment center’s admissions volume.

Two documents are essential for vetting. First, the consultant’s fee schedule, with every performance trigger clearly listed and defined. Second, a written disclosure of all subcontractors, referral relationships, and revenue-share arrangements the consultant maintains with call centers, directories, or other treatment operators. A consultant unwilling to disclose these details is asking the treatment center to sign a contract that cannot withstand legal scrutiny.

Neutral Matching Claims After the R360 Judgment

The R360 case sets another important precedent. The FTC alleged that R360 misled consumers by claiming to connect them with treatment centers selected through a rigorous, expert-led evaluation, when placements were actually driven by paid relationships ¹². The court issued a $3.8 million civil penalty judgment in May 2022. Any consultant offering a “treatment finder,” “admissions network,” “expert matching,” or “clinically vetted placement” product is operating in an area already scrutinized by the FTC.

The financial implications are significant. Evoke Wellness settled its impersonation case for $1.9 million ², while R360’s judgment for misrepresenting its selection process reached $3.8 million ¹². A documented vetting process—including an RFP, legal review of disclosures, BAA execution, and a claims-substantiation walkthrough—costs a fraction of these figures and provides a defensible record for regulators.

For any matching, directory, or referral offering in a consultant’s proposal, concrete requirements include:

• Identifying facility ownership
• Disclosing all financial relationships between the referral service and recommended centers
• Describing the specific criteria for routing callers
• Labeling paid placements as advertising

If neutrality, independence, or expert screening is claimed, the consultant must provide the underlying evaluation methodology and reviewer credentials. Any undocumented language should be removed from ad copy, landing pages, and call scripts before launch.

Account Ownership, Reporting Access, and Third-Party Verification

Effective measurement relies on clear ownership of digital assets. The contract should explicitly state that the treatment center owns the following, with the consultant granted administrative access while the center retains full ownership and control:

• Google Ads account
• Google Business Profile
• Google Analytics property
• Meta Business Manager assets
• Search Console property
• Call-tracking instance
• CRM tenant
• All domains, subdomains, and landing-page hosting environments used in the engagement

Reporting terms must specify access to raw data, not just screenshots. This means row-level exports from analytics, call-tracking, and the CRM, provided on a defined cadence, with a data dictionary mapping terms like “qualified call” or “completed VOB” to the exact filter logic used. Attribution rules should be documented and versioned to prevent silent inflation of reported cost per admission due to mid-quarter changes in conversion definitions.

The contract should include the right to independent verification, allowing the center to bring in a third-party auditor to review tag configurations, BAA coverage, and reporting calculations without triggering a fee dispute ^{7, 8}. The exit clause should mandate full account handover, subprocessor lists, and creative assets within a specified timeframe.

Language Access, Accessibility, and Trust as Leading Indicators

Accessibility reflects operational quality within the marketing funnel and can prevent enforcement issues. Section 1557 requires covered health programs to provide meaningful language access that is free, accurate, timely, and protects privacy and independent decision-making ¹³. It also mandates effective communication for individuals with disabilities and accessible electronic and information technology, with limited exceptions ¹⁴. This applies to a consultant’s website, admissions forms, chat flows, video assets, and downloadable materials when the center is a covered entity.

The contract should require WCAG-aligned accessibility testing for all new landing pages and admissions workflows, documented remediation cycles, and a language-access plan. This plan should name the qualified interpretation vendor and outline the workflow for non-English inbound calls. Machine translation on service pages is not an adequate substitute for a comprehensive plan ¹³.

These signals also predict conversion quality. A 2025 systematic review on trust in digital healthcare identified privacy, perceived risk, data accuracy, and human interaction as factors influencing consumer adoption and engagement with digital health experiences ¹⁵. For an admissions funnel, this means page-load reliability, honest claim language, transparent privacy practices, accessible forms, and quick handoffs to named human contacts are leading indicators of qualified VOBs—metrics that are reportable, contractable, and worth measuring alongside CPA.